Fierce Healthcare August 21, 2024
Virtual marketplace Sesame rolled out a new weight loss program that gives eligible consumers access to compounded semaglutide, an ingredient in blockbuster obesity drugs Wegovy and Ozempic, for $249 a month.
As consumers’ appetite for weight loss drugs continues to grow, many virtual care companies are jumping in to offer compounded GLP-1 medications as the branded drugs are often in short supply. The branded drugs also can be more expensive.
As the weight loss drug market grows, some virtual care players seem to be competing on price.
Sesame unveiled on Wednesday its Success by Sesame clinical, direct-to-consumer weight loss program. The company is making compounded semaglutide available to clinically eligible customers “at cost,” with no retail price markup.
The...
Today's Sponsors
Today's Sponsor